Phase 1/2a Study of ANPD001 in Parkinson Disease
Part of paid clinical trials in Tucson, Arizona.
- Sponsor
- Aspen Neuroscience
- Study ID
- NCT06344026
- Phase
- PHASE1
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- ANPD001 — BIOLOGICALBiologic: ANPD001 is an experimental product derived from the patient's own skin cells converted to induced pluripotent stem cells. The stem cells were differentiated into precursors for brain cells that produce dopamine.
- Custom Device — DEVICEA custom device to facilitate slow injection of small volumes of investigational drugs (including cell therapies), under MRI guidance
Study Details
This clinical trial is designed to test the safety and tolerability of injecting ANPD001 cells that will mature into dopamine-producing cells into the brain of participants with Parkinson Disease. All participants will have ANPD001 cells manufactured from their own previously collected cells.
Key Dates
- Start date
- Jan 23, 2024
- Status verified
- May 2026
- Primary completion
- Mar 30, 2027
- Completion
- Apr 30, 2030
Study Design
- Enrollment
- 9 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: ANPD001
Primary Outcome Measure
Incidence and severity of treatment emergent adverse events (Safety and Tolerability) [ Time Frame: 1 year (primary follow up) ]
Locations (9)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Arizona - Banner Health | Tucson | Arizona | 85724 | - |
| Scripps Health | La Jolla | California | 92037 | - |
| University of California, Los Angeles | Los Angeles | California | 90095 | - |
| University of California, Irvine | Orange | California | 92868 | - |
| University of California, San Diego | San Diego | California | 92037 | - |
| University of California, San Francisco | San Francisco | California | 94143 | - |
| University of Colorado | Aurora | Colorado | 80045 | - |
| Emory University | Atlanta | Georgia | 30322 | - |
| Feinstein Institutes | Manhasset | New York | 11030 | - |
Find similar trials in Tucson, AZ
By condition
By specialty
Related Studies
- Natural History Study of SynucleinopathiesRecruiting · NYU Langone Health · Boston, Massachusetts
- Effects of Stimulation Patterns of Deep Brain StimulationEnrolling By Invitation · Duke University · Gainesville, Florida
- North American Prodromal Synucleinopathy ConsortiumEnrolling By Invitation · Washington University School of Medicine · Sun City, Arizona
- Deep Brain Stimulation (DBS) Retrospective Outcomes StudyRecruiting · Boston Scientific Corporation · Phoenix, Arizona